Advertisement
Advertisement

CVS

CVS logo

CVS HEALTH CORPORATION

78.36
USD
Sponsored
+2.03
+2.66%
Feb 06, 16:00 UTC -5
Closed
exchange

After-Market

78.23

-0.12
-0.16%

CVS Earnings Reports

Positive Surprise Ratio

CVS beat 37 of 39 last estimates.

95%

Next Report

Next Week
Date of Next Report
Feb 11, 2026
Estimate for Q4 25 (Revenue/ EPS)
$104.63B
/
$1.00
Implied change from Q3 25 (Revenue/ EPS)
+1.71%
/
-37.50%
Implied change from Q4 24 (Revenue/ EPS)
+7.08%
/
-15.97%

CVS HEALTH CORPORATION earnings per share and revenue

On Oct 29, 2025, CVS reported earnings of 1.60 USD per share (EPS) for Q3 25, beating the estimate of 1.38 USD, resulting in a 15.69% surprise. Revenue reached 102.87 billion, compared to an expected 99.84 billion, with a 3.04% difference. The market reacted with a -1.95% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 26 analysts forecast an EPS of 1.00 USD, with revenue projected to reach 104.63 billion USD, implying an decrease of -37.50% EPS, and increase of 1.71% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
logo
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
logo
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
logo
Cencora, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$4.07
Actual
$4.08
Surprise
+0.16%
logo
Revvity, Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$1.58
Actual
$1.70
Surprise
+7.45%
logo
InnovAge Holding Corp. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
$0.04
Actual
$0.08
Surprise
+96.08%
logo
Embecta Corp. Common Stock
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.68
Actual
$0.71
Surprise
+3.89%
FAQ
For Q3 2025, CVS HEALTH CORPORATION reported EPS of $1.60, beating estimates by 15.69%, and revenue of $102.87B, 3.04% above expectations.
The stock price moved down -1.95%, changed from $82.20 before the earnings release to $80.60 the day after.
The next earning report is scheduled for Feb 11, 2026.
Based on 26 analysts, CVS HEALTH CORPORATION is expected to report EPS of $1.00 and revenue of $104.63B for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement